Point72 Asset Management, L.P.

Position in RGNX — REGENXBIO Inc.

CIK 1603466 STAMFORD, CT

Position in RGNX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$1,171,448

+$690,719 QoQ

Shares Held

139,791

+318.7% QoQ

Ownership

0.270%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2020

12 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Point72 Asset Management, L.P. holds $2,393,298,297 across 187 Biotechnology names. RGNX ranks #118 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	APLS	Apellis Pharmaceuticals, Inc.	4,183,918	$168,319,021
2	MDGL	Madrigal Pharmaceuticals, Inc.	225,510	$118,047,719
3	CLDX	Celldex Therapeutics, Inc.	3,229,939	$102,453,665
4	RYTM	Rhythm Pharmaceuticals, Inc.	846,801	$73,646,282
5	AXSM	Axsome Therapeutics, Inc.	424,750	$71,791,245
6	ABVX	Abivax S.A.	637,736	$71,011,903
7	LEGN	Legend Biotech Corp	3,886,017	$70,298,047
8	JAZZ	Jazz Pharmaceuticals plc	358,634	$67,799,757

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,171,448	139,791	+318.7%	Shares	Defined	2026-05-15
2025-12-31	$480,729	33,384	+16592.0%	Shares	Defined	2026-02-17
2024-12-31	$1,546	200	-87.5%	Shares	Defined	2025-02-14
2024-03-31	$33,712	1,600	+22757.1%	Shares	Defined	2024-05-15
2023-06-30	$139	7	-100.0%	Shares	Defined	2023-08-14
2022-09-30	$488,955	18,500	-96.7%	Shares	Defined	2022-11-14
2022-06-30	$14,017,250	567,500	+9.7%	Shares	Defined	2022-08-15
2022-03-31	$17,168,091	517,267	+216.2%	Shares	Defined	2022-05-16
2021-06-30	$6,356,170	163,608	-81.9%	Shares	Defined	2021-08-16
2021-03-31	$30,913,893	906,300	+580.4%	Shares	Defined	2021-05-17
2020-12-31	$6,041,952	133,200	-27.5%	Shares	Defined	2021-02-16
2020-06-30	$6,767,733	183,756	—	Shares	Defined	2020-08-14
No filing history on record for this holder in this stock.